US10655128B2 - Compositions and methods for modulating MECP2 expression - Google Patents
4.6 (709) In stock
US20220226361A1 - Compositions and Methods for Modulating MECP2 Expression - Google Patents
Transcriptional Inhibition of the Mecp2 Promoter by MeCP2E1 and MeCP2E2 Isoforms Suggests Negative Auto-Regulatory Feedback that can be Moderated by Metformin
Aging is associated with a systemic length-associated transcriptome imbalance
WO2013173605A1 - Compositions and methods for modulating pten expression - Google Patents
WO2013173637A1 - Compositions and methods for modulating gene expression - Google Patents
MeCP2 Represses the Rate of Transcriptional Initiation of Highly Methylated Long Genes - ScienceDirect
IJMS, Free Full-Text
MeCP2 and transcriptional control of eukaryotic gene expression - ScienceDirect
US20220226361A1 - Compositions and Methods for Modulating MECP2 Expression - Google Patents
US10655128B2 - Compositions and methods for modulating MECP2 expression - Google Patents
Stem Cell-Derived Exosomes as New Horizon for Cell-Free Therapeutic Development: Current Status and Prospects
Mitochondrial modulation with leriglitazone as a potential treatment for Rett syndrome, Journal of Translational Medicine
Mitochondrial modulation with leriglitazone as a potential treatment for Rett syndrome, Journal of Translational Medicine